Evidence map›Paper›PMID 33520786›Full record

ArticleAvicenna journal of medicine

Impact of a division-wide bundle on

Elizabeth Wenqian Wang, Ashlee Weekley, Jennifer McCarty, Hoonmo Koo, Bradley Lembcke, Mayar Al Mohajer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Avicenna journal of medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elizabeth Wenqian WangDepartment of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ashlee WeekleyDepartment of Infection Prevention & Control, CHI Baylor St. Luke's Medical Center, Houston, Texas, USA.
Jennifer McCartyDepartment of Infection Prevention & Control, CHI Baylor St. Luke's Medical Center, Houston, Texas, USA.
Hoonmo KooDepartment of Infection Prevention & Control, CHI Baylor St. Luke's Medical Center, Houston, Texas, USA.
Bradley LembckeDepartment of Infection Prevention & Control, CHI Baylor St. Luke's Medical Center, Houston, Texas, USA.
Mayar Al MohajerDepartment of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUpdated international guidelines recommend the use of a two-step algorithm (glutamate dehydrogenase [GDH] or nucleic-acid amplification test [NAAT] plus toxin) rather than NAAT alone for the diagnosis of MATERIALS AND

methodsThe new bundle was implemented in April 2018. This bundle was implemented across five hospitals in Catholic Health Initiatives (CHI) Texas Division. The bundle included a switch from NAAT to a two-step process (GDH and toxin). We placed the new test in an order panel which included enteric isolation and required indications for

resultsIn the pre-intervention period, 15.5% of the total 3513

conclusionThe new testing bundle led to a marked reduction in hospital-acquired CDI and unnecessary treatment, reduction in

Indexed as

C. difficilecostdiagnostic stewardshipDOTtesting

Identifiers

PMID33520786
PMCPMC7839267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.